Metabolically Healthy Obese and Incident Cardiovascular Disease Events Among 3.5 Million Men and Women

Journal of the American College of Cardiology

Volumn 70, Issue 12, 2017, Pages 1429-1437

  Caleyachetty, Rishi ^a   Thomas, G Neil ^a   Toulis, Konstantinos A ^a,b   Mohammed, Nuredin ^a   Gokhale, Krishna M ^a   Balachandran, Kumarendran ^a,c   Nirantharakumar, Krishnarajah ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b 424 General Army Hospital   (Greece)

^c UNIVERSITY OF KELANIYA   (Sri Lanka)

Author keywords

cerebrovascular disease; coronary heart disease; heart failure; obesity; overweight; phenotype; weight

Indexed keywords

ADULT; ARTICLE; BODY MASS; BODY SIZE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTRONIC HEALTH RECORD; FEMALE; FOLLOW UP; HEART FAILURE; HIGH RISK POPULATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLICALLY BENIGN OBESITY; MORBIDITY; OBESITY; PERIPHERAL VASCULAR DISEASE; PHENOTYPE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; UNDERWEIGHT; CARDIOVASCULAR DISEASES; COMPLICATION; INCIDENCE; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 85031117659     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.07.763     Document Type: Article

References (39)

1. Guh, D.P., Zhang, W., Bansback, N., Amarsi, Z., Birmingham, C.L., Anis, A.H., The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health, 9, 2009, 88.
2. NCD Risk Factor Collaboration. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 387 (2016), 1377–1396.
3. Lu, Y., Hajifathalian, K., Ezzati, M., Woodward, M., Rimm, E.B., Danaei, G., Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet 383 (2014), 970–983.
4. Rey-Lopez, J.P., de Rezende, L.F., de Sa, T.H., Stamatakis, E., Is the metabolically healthy obesity phenotype an irrelevant artifact for public health?. Am J Epidemiol 182 (2015), 737–741.
5. Bradshaw, P.T., Stevens, J., Invited commentary: limitations and usefulness of the metabolically healthy obesity phenotype. Am J Epidemiol 182 (2015), 742–744.
6. Tomiyama, A.J., Hunger, J.M., Nguyen-Cuu, J., Wells, C., Weight and cardiometabolic health: new perspectives. Int J Obes (Lond), 40, 2016, 1331.
7. Dhurandhar, E.J., The downfalls of BMI-focused policies. Int J Obes (Lond) 40 (2016), 729–730.
8. Caleyachetty, R., Meunnig, P., Kengne, A.P., Misclassification of cardiometabolic health when using body mass index categories. Int J Obes (Lond), 40, 2016, 1332.
9. Zheng, R., Zhou, D., Zhu, Y., The long-term prognosis of cardiovascular disease and all-cause mortality for metabolically healthy obesity: a systematic review and meta-analysis. J Epidemiol Community Health 70 (2016), 1024–1031.
10. Kramer, C.K., Zinman, B., Retnakaran, R., Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med 159 (2013), 758–769.
11. Fan, J., Song, Y., Chen, Y., Hui, R., Zhang, W., Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int J Cardiol 168 (2013), 4761–4768.
12. Vision. The Health Improvement Network (THIN). Available at: https://www.visionhealth.co.uk/portfolio-items/the-health-improvement-network-thin/. Accessed August 9, 2017.
13. Blak, B.T., Thompson, M., Dattani, H., Bourke, A., Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care 19 (2011), 251–255.
14. Lewis, J.D., Schinnar, R., Bilker, W.B., Wang, X., Strom, B.L., Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 16 (2007), 393–401.
15. Townsend, P., Phillimore, P., Beattie, A., The construction of a measure of deprivation. Health and Deprivation: Inequality and the North. 1988, Routledge, London.
16. Orimo, H., Ito, H., Suzuki, T., Araki, A., Hosoi, T., Sawabe, M., Reviewing the definition of “elderly.”. Geriatr Gerontol Int 6 (2006), 149–158.
17. Criqui, M.H., Aboyans, V., Epidemiology of peripheral artery disease. Circ Res 116 (2015), 1509–1526.
18. Gaist, D., Wallander, M.A., Gonzalez-Perez, A., Garcia-Rodriguez, L.A., Incidence of hemorrhagic stroke in the general population: validation of data from The Health Improvement Network. Pharmacoepidemiol Drug Saf 22 (2013), 176–182.
19. Hammad, T.A., McAdams, M.A., Feight, A., Iyasu, S., Dal Pan, G.J., Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database. Pharmacoepidemiol Drug Saf 17 (2008), 1197–1201.
20. Ruigomez, A., Martin-Merino, E., Rodriguez, L.A., Validation of ischemic cerebrovascular diagnoses in the health improvement network (THIN). Pharmacoepidemiol Drug Saf 19 (2010), 579–585.
21. St-Onge, M.P., Janssen, I., Heymsfield, S.B., Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. Diabetes Care 27 (2004), 2222–2228.
22. Wildman, R.P., Muntner, P., Reynolds, K., et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 168 (2008), 1617–1624.
23. Siu, A.L., Screening for abnormal blood glucose and type 2 diabetes mellitus. Ann Intern Med, 165, 2016, 225.
24. Mongraw-Chaffin, M.L., Peters, S.A., Huxley, R.R., Woodward, M., The sex-specific association between BMI and coronary heart disease: a systematic review and meta-analysis of 95 cohorts with 1.2 million participants. Lancet Diabetes Endocrinol 3 (2015), 437–449.
25. Van Gaal, L.F., Mertens, I.L., De Block, C.E., Mechanisms linking obesity with cardiovascular disease. Nature 444 (2006), 875–880.
26. Bowlin, S.J., Medalie, J.H., Flocke, S.A., Zyzanski, S.J., Goldbourt, U., Epidemiology of intermittent claudication in middle-aged men. Am J Epidemiol 140 (1994), 418–430.
27. Allison, M.A., Criqui, M.H., McClelland, R.L., et al. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 48 (2006), 1190–1197.
28. Murabito, J.M., Evans, J.C., Nieto, K., Larson, M.G., Levy, D., Wilson, P.W., Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 143 (2002), 961–965.
29. Hooi, J.D., Kester, A.D., Stoffers, H.E., Overdijk, M.M., van Ree, J.W., Knottnerus, J.A., Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: a longitudinal study. Am J Epidemiol 153 (2001), 666–672.
30. Newman, A.B., Siscovick, D.S., Manolio, T.A., et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 88 (1993), 837–845.
31. Kannel, W.B., McGee, D.L., Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc 33 (1985), 13–18.
32. Beks, P.J., Mackaay, A.J., de Neeling, J.N., de Vries, H., Bouter, L.M., Heine, R.J., Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. Diabetologia 38 (1995), 86–96.
33. Prentice, A.M., Jebb, S.A., Beyond body mass index. Obes Rev 2 (2001), 141–147.
34. Thomas, M.C., Walker, M.K., Emberson, J.R., et al. Prevalence of undiagnosed type 2 diabetes and impaired fasting glucose in older British men and women. Diabet Med 22 (2005), 789–793.
35. Falaschetti, E., Mindell, J., Knott, C., Poulter, N., Hypertension management in England: a serial cross-sectional study from 1994 to 2011. Lancet 383 (2014), 1912–1919.
36. Walley, A.J., Asher, J.E., Froguel, P., The genetic contribution to non-syndromic human obesity. Nat Rev Genet 10 (2009), 431–442.
37. Stefan, N., Haring, H.U., Hu, F.B., Schulze, M.B., Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol 1 (2013), 152–162.
38. Hunger, J.M., Tomiyama, A.J., A call to shift the public health focus away from weight. Am J Public Health, 105, 2015, e3.
39. Tomiyama, A.J., Hunger, J.M., Nguyen-Cuu, J., Wells, C., Misclassification of cardiometabolic health when using body mass index categories in NHANES 2005-2012. Int J Obes (Lond) 40 (2016), 883–886.